Abstract:1605 Objectives: Immunoglobulin (Ig) heavy chain framework region (FR) of V1 family has been verified to be a major determinant of malignant phenotype of V1 family B-cell lymphoma. The aim of this study was to investigate the possibility of using radioiodine labeled FR antisense oligonucleotides (ASONs) as an imaging agent or antisense therapeutic radiopharmaceutical in lymphoma. Methods: A 18-mer partial phosphorothioate oligonucleotide sequence was synthesized and grafted in 5′with a tyramine group which was further radio iodinated. Radio iodination of the tyramine derivatized oligonucleotides was performed using the chloramine T method.1)Normal CD-1 mice were injected via a tail vein with 148 kBq 125I-FR-ASON (2~3μg). Animals were sacrificed at 1, 2, 4 and 24 h and tissue samples were studied.2)Liposome-mediated 3.33 MBq 131I-FR-ASON(7 ~9 μg)were injected intratumorally tumor-bearing BALB/c mice (6 weeks after inoculation of 107 Namalwa cells) meanwhile liposome-mediated 131I labeled sense oligonucleotides serving as controls. Biodistribution was monitored by sequential scintigraphy and organ radioactivity measurement at 24 h after injection. Percentage of the injected dose per gram (%ID/g) of tumor and tumor/ non-tumor tissue ratios (T/NT) were calculated for each group of mice and the difference between two groups was assessed. Results: The 5′tyramine group allowed specific and stable radio labeling of the ASON with radioiodine. The radioactivity reached its peak at 1 h after injection, and then decreased rapidly in normal mice after intravenous administration of 125I-FR-ASON.The liver, stomach and intestine played an important role in biodistribution and radioactivity counts were low in bone, brain and blood. When 131I-FR-ASON injected intratumorally into mice grafted with Namalwa cell line, images showed tracer accumulate in tumor. Immediately after intratumoral administration, only tumor was visible. Scintiscans performed at 1 and 2 h showed elimination of the tracer from the tumor to the abdomen and at 24 h tumor was clearly seen. %ID/g of tumor and T/NT ratios for the sense group (control) were significantly lower (P Conclusions: Radio labeled Ig FR ASON showed high specificity in V1 family B-cell lymphoma, and it should be considered further for nuclear medicine imaging application and radionuclide antisense therapy.

Delivery of Radioiodinated Antisense Oligonucleotides in Long Circulating Liposomes in Vivo

An Anionic Long‐circulating Liposome That Improves Radioiodinated Antisense Oligonucleotide Delivery in Vitro and in Vivo

Anionic Long‐circulating Liposomes for Delivery of Radioiodinated Antisense Oligonucleotides

Multifunctional Nanoparticles Combining Host-Guest Interaction of Cb[7] and Auns for Light-Promoted Endosome Escape and High Gene Transfection

Preparation of Anionic Long Circulating Liposomes and Uptake by MCF-7 Breast Cancer Cells

[Anionic Long Circulation Liposomes Mediated Antisense Scintigraphy in Tumor-Bearing Rats].

In vitro and in vivo evaluation of cationic liposomes containing zoledronic acid as anticancer agent

Co-delivery of Aurora-A inhibitor XY-4 and Bcl-xl siRNA enhances antitumor efficacy for melanoma therapy

Study on Biodistribution and Imaging of Radioiodinated Antisense Oligonucleotides in Nude Mice Bearing Human Lymphoma

Delivery of Sirna by MRI-visible Nanovehicles to Overcome Drug Resistance in MCF-7/ADR Human Breast Cancer Cells.

An acoustic/thermo-responsive hybrid system for advanced doxorubicin delivery in tumor treatment

Ultralong Circulating Choline Phosphate Liposomal Nanomedicines for Cascaded Chemo-Radiotherapy.

Selective Delivery of an Anticancer Drug with Aptamer-Functionalized Liposomes to Breast Cancer Cells in Vitro and in Vivo.

Preparation of Stealth Cationic Liposome Loaded with Doxorubicin and Cell Studies in Vitro

Cationic liposomes co-deliver chemotherapeutics and siRNA for the treatment of breast cancer

Preparation of DSPE-PEG-cRGD Modified Cationic Liposomes for Delivery of OC-2 Shrna and the Antitumor Effects on Breast Cancer

RGD-modified Liposomes Enhance Efficiency of Aclacinomycin A Delivery: Evaluation of Their Effect in Lung Cancer.

Low-density Lipoprotein-Coupled Micelles with Reduction and Ph Dual Sensitivity for Intelligent Co-Delivery of Paclitaxel and Sirna to Breast Tumor

Replacing cholesterol with asiatic acid to prolong circulation and enhance anti-metastatic effects of non-PEGylated liposomes

Enhanced Antitumor Efficacy and Reduced Systemic Toxicity of Sulfatide-Containing Nanoliposomal Doxorubicin in a Xenograft Model of Colorectal Cancer.

Application Of Ultrasonic Gas-Filled Liposomes In Enhancing Transfer For Breast Cancer-Related Antisense Oligonucleotides: An Experimental Study